Urology Times

John Sfakianos, MD, on integrating ctDNA into bladder cancer trials

Oct 1, 2026 · 0:03:54

Listen to Episode

✨ AI Summary

Dr. Sfakianos explains ctDNA's role in bladder cancer trials.
Discusses optimal integration strategies for ctDNA.
Highlights potential for personalized treatment approaches.

Guests on This Episode

JM

John Sfakianos, MD

1 podcast appearance

More from Urology Times

When surgery may be needed for prolonged ischemic priapism

Oct 12, 2026 · 0:02:34

Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence

Oct 12, 2026 · 0:03:53

How can urologists separate personalized medicine from marketing?

Oct 9, 2026 · 0:04:29

Why ctDNA serves as a rule-out in NeoBLAST's response assessment

Oct 8, 2026 · 0:06:56

View all episodes →